Cargando…
Preliminary results of using ALAnerv® in subacute motor incomplete paraplegics
Rationale: To assess whether using ALAnerv® contributes to improvements of outcomes obtained in post SCI patients. Objective: A prospective controlled clinical survey also to evaluate the safety and efficacy of ALAnerv® (2cps/ day for 28 days) in motor incomplete (AIS/ Frankel C) paraplegic subacute...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Carol Davila University Press
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556909/ https://www.ncbi.nlm.nih.gov/pubmed/26351530 |